Antineoplastic and anti-inflammatory effects of PPAR ligands in colitis.
Su
C G
CG
Lewis
J D
JD
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001629:Bezafibrate / Q000627:therapeutic use*; D002839:Chromans / Q000627:therapeutic use*; D003092:Colitis / Q000188:drug therapy* / Q000473:pathology; D003106:Colon / Q000187:drug effects / Q000473:pathology; D004268:DNA-Binding Proteins / Q000627:therapeutic use; D051381:Rats; D011916:Rats, Inbred F344; D018160:Receptors, Cytoplasmic and Nuclear / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000627:therapeutic use*; D000077288:Troglitazone
D000975:Antioxidants; D002839:Chromans; D004268:DNA-Binding Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D000077288:Troglitazone; D001629:Bezafibrate